Probiotic Innovation in Menopause: Expert Perspectives and Clinical Evidence
06 Nov 2025 | AB-BIOTICS Kaneka Probiotics
As the demand for science-backed, non-hormonal solutions in menopause care continues to grow, consumer health companies face increasing pressure to bring clinically credible products to market.
This webinar will explore how a precision three-strain probiotic—developed by AB-BIOTICS and Kaneka Probiotics—addresses this need with targeted action on the estrobolome, a key regulator of estrogen metabolism.
The program will cover two key areas: the estrobolome as a novel target in menopause care, with practical guidance on probiotic use, and the clinical evidence supporting Gyntima® / KABP® Menopause, including new clinical trial data.
Designed for professionals in pharmaceutical and consumer health companies, this 45-minute session blends scientific rigor with real-world application.
The agenda is structured to provide a comprehensive overview, from foundational science to clinical evidence and commercial opportunities, and will conclude with a live Q&A.
Brought to you by
Prof
Senior Journalist Nutrition Insight
AB BIOTICS
Franco Vicariotto
Prof
Jolanda van Hal
Senior Journalist Nutrition Insight
Marta Perez
AB BIOTICS
